212 related articles for article (PubMed ID: 35590113)
1. Short-term, low-dose etoposide in refractory adult-onset Still's disease-associated macrophage activation syndrome.
Wang R; Li T; Ye S; Lv L; Chen S; Wang X; Bao CD; Fu Q
Clin Rheumatol; 2022 Sep; 41(9):2817-2823. PubMed ID: 35590113
[TBL] [Abstract][Full Text] [Related]
2. Successful use of short-term add-on tocilizumab for refractory adult-onset still's disease with macrophage activation syndrome despite treatment with high-dose glucocorticoids, cyclosporine, and etoposide.
Ohmura SI; Uehara K; Yamabe T; Tamechika S; Maeda S; Naniwa T
Mod Rheumatol Case Rep; 2020 Jul; 4(2):202-207. PubMed ID: 33086994
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
[TBL] [Abstract][Full Text] [Related]
4. Macrophage activation syndrome associated with adult-onset Still's disease: a multicenter retrospective analysis.
Wang R; Li T; Ye S; Tan W; Zhao C; Li Y; de Bao C; Fu Q
Clin Rheumatol; 2020 Aug; 39(8):2379-2386. PubMed ID: 32130578
[TBL] [Abstract][Full Text] [Related]
5. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
Lenert A; Yao Q
Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
[TBL] [Abstract][Full Text] [Related]
6. Baseline clinical features predicting macrophage activation syndrome in patients with systemic adult-onset Still's disease receiving interleukin-6 inhibitor treatment.
Naniwa T; Yamabe T; Ohmura SI; Uehara K; Tamechika SY; Maeda S; Isogai S; Wada J
Int J Rheum Dis; 2022 Sep; 25(9):1003-1012. PubMed ID: 35719030
[TBL] [Abstract][Full Text] [Related]
7. A Recurrent Case of Adult-onset Still's Disease with Concurrent Acalculous Cholecystitis and Macrophage Activation Syndrome/Hemophagocytic Lymphohistiocytosis Successfully Treated with Combination Immunosuppressive Therapy.
Arai Y; Ishikawa Y; Abe K; Kato Y; Abe D; Fujiwara M; Kita Y
Intern Med; 2021 Jun; 60(12):1955-1961. PubMed ID: 33518559
[TBL] [Abstract][Full Text] [Related]
8. Macrophage activation syndrome in patients with adult-onset Still's disease under tocilizumab treatment: A single-center observational study.
Yamabe T; Ohmura SI; Uehara K; Naniwa T
Mod Rheumatol; 2022 Jan; 32(1):169-176. PubMed ID: 33719871
[TBL] [Abstract][Full Text] [Related]
9. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease.
Jia J; Wang M; Ma Y; Meng J; Zhu D; Chen X; Shi H; Sun Y; Liu H; Cheng X; Su Y; Ye J; Chi H; Liu T; Zhou Z; Wang F; Chen L; Yi D; Xiao Y; Yang C; Teng J; Hu Q
BMC Med; 2023 Dec; 21(1):507. PubMed ID: 38124139
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of MS-Score and HScore in timeliness of diagnosis of macrophage activation syndrome associated with adult-onset Still's disease].
Peng Z; Gao XM; Zhou S; Wu CY; Zhao JL; Xu D; Li MT; Peng JM; Li J; Wang Q; Tian XF; Zeng X
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2210-2214. PubMed ID: 35872586
[TBL] [Abstract][Full Text] [Related]
13. Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series.
Bindoli S; Galozzi P; Doria A; Sfriso P
Joint Bone Spine; 2023 Mar; 90(2):105524. PubMed ID: 36623798
[TBL] [Abstract][Full Text] [Related]
14. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?
Tada Y; Inokuchi S; Maruyama A; Suematsu R; Sakai M; Sadanaga Y; Ono N; Arinobu Y; Koarada S
Rheumatol Int; 2019 Jan; 39(1):97-104. PubMed ID: 30051293
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and follow-up analysis of adult-onset Still's disease complicated by hemophagocytic lymphohistiocytosis.
Zhang Y; Yang Y; Bai Y; Yang D; Xiong Y; Zeng X
Clin Rheumatol; 2016 May; 35(5):1145-51. PubMed ID: 26809798
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the multivisceral involvement on adult-onset Still's disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study.
Di Cola I; Bruno F; Berardicurti O; Monti R; Conforti A; Di Sibio A; Pavlych V; Masciocchi C; Barile A; Cipriani P; Ruscitti P
Clin Rheumatol; 2021 Oct; 40(10):3971-3978. PubMed ID: 33855668
[TBL] [Abstract][Full Text] [Related]
17. Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.
Ruscitti P; Rago C; Breda L; Cipriani P; Liakouli V; Berardicurti O; Carubbi F; Di Battista C; Verrotti A; Giacomelli R
Clin Rheumatol; 2017 Dec; 36(12):2839-2845. PubMed ID: 28914368
[TBL] [Abstract][Full Text] [Related]
18. Elderly-onset Still's Disease Complicated by Macrophage Activation Syndrome: A Case Report and Review of the Literature.
Suda T; Zoshima T; Takeji A; Suzuki Y; Mizushima I; Yamada K; Nakashima A; Yachie A; Kawano M
Intern Med; 2020 Mar; 59(5):721-728. PubMed ID: 31708548
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors and prognosis of macrophage activation syndrome associated with adult-onset Still's disease.
Yang XP; Wang M; Li TF; Li W; Zhang L; Liu SY
Clin Exp Rheumatol; 2019; 37 Suppl 121(6):83-88. PubMed ID: 31287402
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive review on adult onset Still's disease.
Giacomelli R; Ruscitti P; Shoenfeld Y
J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]